• Bicanic T, Muzoora C, Brouwer AE et al. (2009) Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV-Associated Cryptococcal Meningitis: analysis of a Combined Cohort of 262 Patients. Clinical infectious diseases 49, 7029.
  • Chariyalertsak S, Sirisanthana T, Saengwonloey O & Nelson KE (2001) Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: regional variation and temporal trends. Clinical Infectious Diseases 32, 955962.
  • Collett G & Parrish A (2007) Fluconazole donation and outcomes assessment in cryptococcal meningitis. South African Medical Journal 97, 175176.
  • French N, Gray K, Watera C et al. (2002) Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 16, 10311038.
  • Jackson A & van der Horst C (2012) New insights in the prevention, diagnosis and treatment of cryptococcal meningitis. Current HIV/AIDS reports 9, 267277.
  • Jarvis J, Lawn S, Vogt M, Bangani N, Wood R & Harrison T (2009) Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clinical Infectious Diseases 48, 856862.
  • Jarvis J, Percival A, Bauman S et al. (2011) Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clinical Infectious Diseases 53, 10191023.
  • Kendi C, Penner J, Koech J et al. (2012) Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings. Postgraduate Medical Journal 15.
  • Lawn S, Harries A, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Liechty CA, Solberg P, Were W et al. (2007) Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Tropical medicine & international health 12, 929935.
  • Lindsley M, Mekha N, Baggett H et al. (2011) Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clinical Infectious Diseases 53, 321325.
  • Longley N, Muzoora C, Taseera K et al. (2008) Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clinical Infectious Diseases 47, 15561561.
  • McCarthy KM, Morgan J, Wannemuehler KA et al. (2006) Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. AIDS 20, 21992206.
  • Menichetti F, Fiorio M, Tosti A et al. (1996) High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clinical infectious diseases 22, 838840.
  • Meya DB, Manabe YC, Castelnuovo B et al. (2010) Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4 +  cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clinical Infectious Diseases 51, 448455.
  • Micol R, Lortholary O, Sar B et al. (2007) Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 45, 555559.
  • Mwaba P, Mwansa J, Chintu C et al. (2001) Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgraduate Medical Journal 77, 769773.
  • Nelson MR, Bower M, Smith D, Reed C, Shanson D & Gazzard B (1990) The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. Journal of Infection 21, 175181.
  • Park B, Wannemuehler K, Marston B, Govender N, Pappas P & Chiller T (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525.
  • Pongsai P, Atamasirikul K & Sungkanuparph S (2010) The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Journal of Infection. 60, 474477.
  • Tansuphasawadikul S, Amornkul PN, Tanchanpong C et al. (1999) Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. Journal of acquired immune deficiency syndromes 21, 326332.
  • The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) group (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Wajanga B, Kalluvya S, Downs J, Johnson W, Fitzgerald D & Peck R (2011) Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study. Journal of the International AIDS Society 14, 48.
  • World Health Organization (2011) Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. World Health Organization, Geneva, Switzerland.